This article is more than 5 years old. Information may no longer be current.

CK-related patents licensed by intellectual property company

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

WEST CONSHOHOCKEN, Pa. — An intellectual property company has licensed what it calls “fundamental patents around conductive keratoplasty technology” and says it plans to commercialize the patents. The company, BTG, which describes itself as an intellectual property and technology commercialization company, announced its plans in a press release.

BTG licensed the patents from RJF Holdings, a company currently in patent litigation with Refractec over alleged infringement of the patents, according to the press release. The press release claims that Richard J. Fugo, MD, developed CK.

Refractec currently markets the CK technology as the ViewPoint CK System in the United States.

The CK technique was approved for the treatment of hyperopia in 2002 and presbyopia in 2004, but “the technology can be developed in the future for all types of refractive surgery,” BTG said in its press release.